about
Chemovirotherapy: combining chemotherapeutic treatment with oncolytic virotherapyOncolytic virus therapy for glioblastoma multiforme: concepts and candidatesViruses as nanomedicine for cancerTargeting pediatric cancer stem cells with oncolytic virotherapyPEG-pHPMAm-based polymeric micelles loaded with doxorubicin-prodrugs in combination antitumor therapy with oncolytic vaccinia viruses.Oncolytic Poxviruses.Oncolytic vaccinia virus therapy of salivary gland carcinomaVirotherapy, gene transfer and immunostimulatory monoclonal antibodies.Oncolytic gene therapy with recombinant vaccinia strain GLV-2b372 efficiently kills hepatocellular carcinoma.Targeting tumor vasculature through oncolytic virotherapy: recent advances.Oncolytic myxoma virus: the path to clinicOncolytic virus efficiency inhibited growth of tumour cells with multiple drug resistant phenotype in vivo and in vitro.Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunityRetargeting of viruses to generate oncolytic agents.Progress of oncolytic viruses in sarcomas.Oncolytic virotherapy for renal cell carcinoma: a novel treatment paradigm?Oncolytic viral therapy: targeting cancer stem cellsGenetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery.Establishing elements of a synthetic biology platform for Vaccinia virus production: BioBrick™ design, serum-free virus production and microcarrier-based cultivation of CV-1 cells.Oncolytic virotherapy: the questions and the promise.The Oncolytic Effect of Respiratory Syncytial Virus (RSV) in Human Skin Cancer Cell Line, A431.Myxoma and vaccinia viruses bind differentially to human leukocytes.Efficacy and Safety of Doubly-Regulated Vaccinia Virus in a Mouse Xenograft Model of Multiple Myeloma.Evaluation of vesicular stomatitis virus mutant as an oncolytic agent against prostate cancer.Anti-tumour activity of oncolytic Western Reserve vaccinia viruses in canine tumour cell lines, xenografts, and fresh tumour biopsies.GMCSF-armed vaccinia virus induces an antitumor immune response.Evolutionary cancer-favoring engineered vaccinia virus for metastatic hepatocellular carcinoma.Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus.Tachypleus tridentatus Lectin Enhances Oncolytic Vaccinia Virus Replication to Suppress In Vivo Hepatocellular Carcinoma Growth.UEG Week 2015 Poster Presentations
P2860
Q26852345-F95EE372-9E57-4196-82BF-77C237B6A030Q27007519-523F93E8-2E14-4A5F-8B4E-7BB0C4BA3F3BQ27690636-70B9415A-9B6A-49D7-AA7C-5C10A505D81AQ34262327-4FBC71DB-942C-4EF0-BA3D-0F7998D11770Q34403672-260383AE-C3E4-4643-997F-2C296C9B705AQ35234349-DAE916AD-C82D-4FD0-88D1-F5C029F41244Q35549696-5FCBD97A-C068-48DC-AB04-BF05D1881AFAQ36456487-58226E1B-1451-45CF-8706-A3BDB584C80DQ36760156-275E4D18-69E4-470C-AA40-9340A736C929Q37031932-29544E87-26F8-47D3-BE2E-FE6F548B8334Q37126088-F69283C4-284A-45E8-A6D1-84627E9F51F2Q37185612-3FAA139E-0745-47A2-923A-263F9DE888A8Q37225198-4BF1A4D2-86F3-40B2-AC0B-41EEE5D7762EQ37982062-386474D7-ED13-4270-AB37-C7A7683ACD26Q37982449-CF6236C3-5E76-4E1F-9065-27A7083E5445Q38008023-1CD6858E-208A-45A6-AAF2-3A4280EE314EQ38212255-F57157F8-B6AE-4C96-8544-0EE6D76322D1Q38673968-CBB2898B-F29B-4C52-9889-5A15872A40F9Q38716258-83F2C0FB-DA80-4070-91BD-4E6DD504BD8DQ38924527-AD35D962-C106-4BD1-832E-2EC98D898136Q39181482-DB5398C8-9B32-4776-8E64-68F9BCDE19E0Q39198482-D79916B9-4431-42C3-8357-F9EE1A8A09E8Q40083001-85B85626-7C54-4BC8-8AE2-9DA910A3D8CBQ41379521-48626A0F-FA02-4179-BD27-E4C8F62BDB94Q41706553-635B9011-6D13-4380-94A9-EF809341D993Q42205083-FCB26E80-0439-4EC6-B19A-3F414FC22737Q42654000-E980F36E-6143-4AB5-8BE1-3424863F6300Q45325487-CEFDF455-0117-403E-AFA2-126225A842E6Q55497249-98586FE2-BC9F-45C3-BC39-FA19A4ECF67DQ56934656-8A9B1ECE-B07F-4D7D-B00B-A8C1BD955A24
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oncolytic vaccinia virus for the treatment of cancer.
@en
Oncolytic vaccinia virus for the treatment of cancer.
@nl
type
label
Oncolytic vaccinia virus for the treatment of cancer.
@en
Oncolytic vaccinia virus for the treatment of cancer.
@nl
prefLabel
Oncolytic vaccinia virus for the treatment of cancer.
@en
Oncolytic vaccinia virus for the treatment of cancer.
@nl
P2860
P1476
Oncolytic vaccinia virus for the treatment of cancer.
@en
P2093
Kilian Guse
Vincenzo Cerullo
P2860
P304
P356
10.1517/14712598.2011.558838
P407
P577
2011-02-22T00:00:00Z